Gender: Male
Clinical Interest for Patients: My clinical interests broadly cover the entire realm of therapeutic endoscopy including management of pancreaticobiliary disease, technically difficult luminal disease and novel endoscopic therapies of obesity. In doing so, I carefully employ various endoscopic techniques including interventional ERCP, interventional EUS, enteroscopy, entersocopy assisted ERCP, endoscopic mucosal resection, crytotherapy, radiofrequency ablation, enteral dilation and stent placement, cystgastrostomy, as well as celiac plexus block and neurolysis. I was brought to the University of Colorado in large part to develop a bariatric endoscopy program. Bariatric endoscopy is an emerging field within gastroenterology addressing not only surgical complications of weight loss procedures but also offering future potential for incisionless endoscopic weight loss therapies. At the University of Colorado, we offer a multidisciplinary approach to weight loss providing both traditional and novel endoscopic techniques to manage early and late problematic outcomes. These low risk procedures offer a means for immediate improvement with nearly no morbidity. Weight regain after initial successful weight loss has been attributed in part to expansion of the surgically restricted stomach and the anastomosis of the small bowel with the stomach. Using incisionless endoscopic suturing both sites may be reconstrained, facilitating weight stability, if not loss. In the near future, we envision offering low risk, reversible endoscopic weight loss procedures for those individuals not immediately appropriate for surgical intervention, be the patient otherwise too ill, obese, or even not overweight enough.
Care Philosophy: Patient satisfcation is the ultimate outcome to which I judge a successful intervention. I strive to provide the best care for my patients and in doing so consider not only the problem at hand but also the person as a whole. As all therapeutic procedures carry risk, I carefully weigh these against the potential benefits, including the patient as part of the therapeutic team.
Personal Interests: In my spare time, I enjoy spending time with family and friends, playing soccer and enjoying the wonderful outdoor opportunities found here in Colorado.

Website
http://www.ncbi.nlm.nih.gov/pubmed?term="Amateau"[Author]

Research Interests
I currently have two ongoing prospective randomized clinical trials; the first is investigating the effects of Mitomycin C in combination with ERCP on primary sclerosing cholangitis and the second is comparing various endoscopic methods of gastric and ostomy revision following weight regain in patients previously managed with gastric bypass. I also have several retrospective studies evaluating therapeutic efficacy and outcomes.

Clinical Interests for Referring Providers: My clinical interests broadly cover the entire realm of therapeutic endoscopy including management of pancreaticobiliary disease, technically difficult luminal disease and novel endoscopic therapies of obesity. In doing so, I carefully employ various endoscopic techniques including interventional ERCP, interventional EUS, enteroscopy, entersocopy assisted ERCP, endoscopic mucosal resection, crytotherapy, radiofrequency ablation, enteral dilation and stent placement, cystgastrostomy, as well as celiac plexus block and neurolysis. I was brought to the University of Colorado in large part to develop a bariatric endoscopy program. Bariatric endoscopy is an emerging field within gastroenterology addressing not only surgical complications of weight loss procedures but also offering future potential for incisionless endoscopic weight loss therapies. At the University of Colorado, we offer a multidisciplinary approach to weight loss providing both traditional and novel endoscopic techniques to manage early and late problematic outcomes. These low risk procedures offer a means for immediate improvement with nearly no morbidity. For instance, we manage postsurgical leaks, fistulae and bleeding through innovative endoscopic suturing or application of large endoscopic clips. Moreover, anastomotic strictures may be approached by balloon dilation with adjunct steroid injection or placement of a removable enteral stent. Late complications, such as biliary stone obstruction, gastric band erosion and weight regain pose technically challenging problems, however we have the expertise to address each. For biliary stone obstruction, or choledocholithiasis, we couple small bowel enteroscopy with ERCP, or in special circumstances coordinate laparoscopic surgical assistance to facilitate stone extraction. Gastric band erosion triggers gastric leak and severe pain, though we can excise and retrieve the band endoscopically with concomitant defect closure. Weight regain after initial successful weight loss has been attributed in part to expansion of the surgically restricted stomach and the anastomosis of the small bowel with the stomach. Using incisionless endoscopic suturing both sites may be reconstrained, facilitating weight stability, if not loss. In the near future, we envision offering low risk, reversible endoscopic weight loss procedures for those individuals not immediately appropriate for surgical intervention, be the patient otherwise too ill, obese, or even not overweight enough.

Research Interest for Referring Providers: I currently have two ongoing prospective randomized clinical trials; the first is investigating the effects of Mitomycin C in combination with ERCP on primary sclerosing cholangitis and the second is comparing various endoscopic methods of gastric and ostomy revision following weight regain in patients previously managed with gastric bypass. I also have several retrospective studies evaluating therapeutic efficacy and outcomes.

CV: Amateau CV 2013 C.docx